I am a Cancer Biologist and Research Scientist at the University of Puerto Rico Comprehensive Cancer Center. I hold a B.S. in Biotechnology from the Interamerican University of Puerto Rico-Arecibo Campus and a Ph.D. in Biochemistry from the University of Puerto Rico Medical Sciences Campus. During my Ph.D., I conducted research under the mentorship of Dr. Suranganie Dharmawardhane, focusing on mechanisms of resistance to anti-EGFR/HER2 therapy in breast cancer. I completed my postdoctoral training at the University of California, San Francisco (UCSF), in the Department of Radiation Oncology, studying the role of TGFβ in preclinical intracranial brain tumor models. Previously, I served as the Director of Research and Development at MBQ Pharma in Puerto Rico, where I developed preclinical studies for MBQ-167, now in clinical trials. Currently, I am focused on understanding the incidence and mortality of colorectal cancer in Puerto Rico, the most prevalent cancer type in the region.